246 related articles for article (PubMed ID: 31140861)
61. Lasing the DNA fragments through β-diketimine framed Knoevenagel condensed Cu(II) and Zn(II) complexes--an in vitro and in vivo approach.
Raman N; Pravin N
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():867-82. PubMed ID: 24161850
[TBL] [Abstract][Full Text] [Related]
62. 1,8-Naphthalimide: A Potent DNA Intercalator and Target for Cancer Therapy.
Tandon R; Luxami V; Kaur H; Tandon N; Paul K
Chem Rec; 2017 Oct; 17(10):956-993. PubMed ID: 28375569
[TBL] [Abstract][Full Text] [Related]
63. Review-Novel synthetic curcuminoids: Not merely an anticancer agent.
Zhang H; Jiang X; Song W; Yang Z
Pak J Pharm Sci; 2019 Jul; 32(4):1723-1747. PubMed ID: 31608897
[TBL] [Abstract][Full Text] [Related]
64. Gold Complexes for Therapeutic Purposes: an Updated Patent Review (2010-2015).
Nardon C; Pettenuzzo N; Fregona D
Curr Med Chem; 2016; 23(29):3374-3403. PubMed ID: 27142288
[TBL] [Abstract][Full Text] [Related]
65. Ruthenium(II) Complexes as Potential Apoptosis Inducers in Chemotherapy.
Zheng K; Wu Q; Wang C; Tan W; Mei W
Anticancer Agents Med Chem; 2017; 17(1):29-39. PubMed ID: 27349451
[TBL] [Abstract][Full Text] [Related]
66. Perspective: the potential of pyrazole-based compounds in medicine.
Keter FK; Darkwa J
Biometals; 2012 Feb; 25(1):9-21. PubMed ID: 22002344
[TBL] [Abstract][Full Text] [Related]
67. Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy.
Liu J; Lai H; Xiong Z; Chen B; Chen T
Chem Commun (Camb); 2019 Aug; 55(67):9904-9914. PubMed ID: 31360938
[TBL] [Abstract][Full Text] [Related]
68. Noble metal-dithiocarbamates precious allies in the fight against cancer.
Nagy EM; Ronconi L; Nardon C; Fregona D
Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
[TBL] [Abstract][Full Text] [Related]
69. Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models.
Lu X; Liu YC; Orvig C; Liang H; Chen ZF
Eur J Med Chem; 2019 Nov; 181():111567. PubMed ID: 31401535
[TBL] [Abstract][Full Text] [Related]
70. Tannic acid-based metal phenolic networks for bio-applications: a review.
Guo Z; Xie W; Lu J; Guo X; Xu J; Xu W; Chi Y; Takuya N; Wu H; Zhao L
J Mater Chem B; 2021 May; 9(20):4098-4110. PubMed ID: 33913461
[TBL] [Abstract][Full Text] [Related]
71. The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study.
Najafi M; Mortezaee K; Rahimifard M; Farhood B; Haghi-Aminjan H
Life Sci; 2020 Sep; 257():118051. PubMed ID: 32634426
[TBL] [Abstract][Full Text] [Related]
72. Silver carbene complexes: An emerging class of anticancer agents.
Kankala S; Thota N; Björkling F; Taylor MK; Vadde R; Balusu R
Drug Dev Res; 2019 Mar; 80(2):188-199. PubMed ID: 30387164
[TBL] [Abstract][Full Text] [Related]
73. Use of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric (Curcuma longa L.) rhizome.
Jiang H; Timmermann BN; Gang DR
J Chromatogr A; 2006 Apr; 1111(1):21-31. PubMed ID: 16490201
[TBL] [Abstract][Full Text] [Related]
74. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--Part I. Editorial.
Kostova I
Anticancer Agents Med Chem; 2010 May; 10(4):270-1. PubMed ID: 20443777
[No Abstract] [Full Text] [Related]
75. Speciation of precious metal anti-cancer complexes by NMR spectroscopy.
Zou T; Sadler PJ
Drug Discov Today Technol; 2015 Sep; 16():7-15. PubMed ID: 26547416
[TBL] [Abstract][Full Text] [Related]
76. Peptide-mediated vectorization of metal complexes: conjugation strategies and biomedical applications.
Soler M; Feliu L; Planas M; Ribas X; Costas M
Dalton Trans; 2016 Aug; 45(33):12970-82. PubMed ID: 27095089
[TBL] [Abstract][Full Text] [Related]
77. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.
Silva MJSA; Gois PMP; Gasser G
Chembiochem; 2021 May; 22(10):1740-1742. PubMed ID: 33507625
[TBL] [Abstract][Full Text] [Related]
78. Metal complexes in medicine and pharmacy - the past and the present II.
Habala L; Valentová J
Ceska Slov Farm; 2020; 69(1):3-16. PubMed ID: 32460505
[TBL] [Abstract][Full Text] [Related]
79. Metallodrugs in cancer nanomedicine.
Peña Q; Wang A; Zaremba O; Shi Y; Scheeren HW; Metselaar JM; Kiessling F; Pallares RM; Wuttke S; Lammers T
Chem Soc Rev; 2022 Apr; 51(7):2544-2582. PubMed ID: 35262108
[TBL] [Abstract][Full Text] [Related]
80. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
